Assessing Nasdaq: Insights From 7 Financial Analysts
Across the recent three months, 7 analysts have shared their insights on Nasdaq (NASDAQ:NDAQ), expressing a variety of opinions spanning from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 2 | 4 | 1 | 0 | 0 |
Last 30D | 0 | 0 | 1 | 0 | 0 |
1M Ago | 1 | 4 | 0 | 0 | 0 |
2M Ago | 1 | 0 | 0 | 0 | 0 |
3M Ago | 0 | 0 | 0 | 0 | 0 |
Analysts have recently evaluated Nasdaq and provided 12-month price targets. The average target is $73.71, accompanied by a high estimate of $80.00 and a low estimate of $64.00. Observing a 0.15% increase, the current average has risen from the previous average price target of $73.60.
Exploring Analyst Ratings: An In-Depth Overview
In examining recent analyst actions, we gain insights into how financial experts perceive Nasdaq. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Andrew Bond | Rosenblatt | Lowers | Neutral | $64.00 | $76.00 |
Benjamin Budish | Barclays | Lowers | Overweight | $73.00 | $76.00 |
Kyle Voigt | Keefe, Bruyette & Woods | Lowers | Outperform | $74.00 | $75.00 |
Andrew Bond | Rosenblatt | Lowers | Buy | $76.00 | $82.00 |
Benjamin Budish | Barclays | Announces | Overweight | $76.00 | - |
Michael Cyprys | Morgan Stanley | Raises | Overweight | $80.00 | $59.00 |
Alexander Blostein | Goldman Sachs | Announces | Buy | $73.00 | - |
Key Insights:
- Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Nasdaq. This information provides ...
Full story available on Benzinga.com